Mark Kronenfeld

Mark Kronenfeld

DirectoratPacira BioSciences· In proxies 2023–2024

Mark Kronenfeld sits on 8 public boards.

Boards1

  • Pacira BioSciencesDirector · 10 yr on the boardIndependentCompensation, Nominating, Governance and Sustainability (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Pacira BioSciencesPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -6%
  2. Edgewise TherapeuticsPublic company · 6 yr
    • Director2020 – Present · 6 yrNo stock prices for these years
  3. HLS TherapeuticsPublic company · 7 yr
    • Director2019 – Present · 7 yrNo stock prices for these years
  4. Mirum PharmaceuticalsPublic company · 7 yr
    • Director2019 – Present · 7 yrNo stock prices for these years
  5. Dynavax Technologies CorporationPublic company · 11 yr
    • Director2015 – Present · 11 yrNo stock prices for these years
  6. Portola PharmaceuticalsPublic company · 11 yr
    • Director2015 – Present · 11 yrNo stock prices for these years
  7. Aratana TherapeuticsPublic company · 12 yr
    • Director2014 – Present · 12 yrNo stock prices for these years
  8. Acadia PharmaceuticalsPublic company · 18 yr
    • Director2008 – Present · 18 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?